SULT2B1 expression was diminished by downregulating c-MYC, thereby restraining glycolytic metabolism to inhibit colon cancer cell proliferation and chemoresistance under condition of knockdown of OLR1 [43]. Here, SULT2B1 is linked to colonic neoplasm.